Data sources

Source-labeled psilocybin and psilocin literature for search, monitoring, export, and citation workflows.

How the research index is built

Eight research sources feed Psilocybin-Research.com PubMed, OpenAlex, Crossref, Europe PMC, ClinicalTrials.gov, PsyArXiv, bioRxiv, and medRxiv provide records that are reconciled into the central research index. psilocybin-research.com PubMed OpenAlex Crossref Europe PMC ClinicalTrials.gov PsyArXiv bioRxiv medRxiv
Source records are fetched, reconciled, and labeled before appearing in the live index. The original sources remain authoritative.

Research workflow

Search, filter, export, analyze, and monitor publications with source labels, publication status, citation links, alerts, API access, and a rights-safe SQLite download. Read about the methods and limitations. Explore the dataset and reuse guide or research trends by year.

Paper citation network

Psychedelics as a Treatment for Alzheimer's Disease Dementia.

Vann Jones SA, O'Kelly A

Publication record · Explore literature

Public tracker catalogue and stored structured reference metadata. External references may have identifiers only. No live external citation lookup is performed.

References — this paper cites (0)

No references identified in the available metadata. This does not establish that none exist.

    Cited by — these papers cite this paper (5)

    1. Transient multidomain functional improvement in advanced Alzheimer’s disease following high-dose psilocybin-containing mushroom administration: a case report 2026-05-28 · Expand citations
    2. Neuroplasticity and Neuro-Generation: The Promise of Psychedelics in Dementia Care 2025-09-02 · Expand citations
    3. Psilocybin-Based Breakthroughs in Natural Medicine 2023-04-30 · Expand citations
    4. Psilocybin to promote synaptogenesis in the brains of patients with mild cognitive impairment 2023-04-05 · Expand citations
    5. Unmet need in depression: Psilocybin, a breakthrough treatment option 2021-01-01 · Expand citations